MORGAN STANLEY PLC/CALL/MERCK & CO./140/0.1/17.01.25 Share Price

Warrant

DE000MB1WWW2

Real-time Bid/Ask 05:31:18 08/07/2024 pm IST
0.32 EUR / 0.34 EUR +13.79% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./140/0.1/17.01.25
Current month-29.27%
1 month-32.56%
Date Price Change
08/24/08 0.31 +6.90%
05/24/05 0.29 +7.41%
04/24/04 0.27 -10.00%
03/24/03 0.3 -16.67%
02/24/02 0.36 -5.26%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 01:39 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB1WWW
ISINDE000MB1WWW2
Date issued 30/12/2022
Strike 140 $
Maturity 17/01/2025 (193 Days)
Parity 10 : 1
Emission price 0.84
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.9
Lowest since issue 0.072
Spread 0.03
Spread %8.82%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus